Markets:

Overview

News

Currencies

International

Treasuries

Verve Therapeutics, Inc. - Common Stock (NQ:VERV)

11.13 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Verve Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Why Is United Airlines Down By Over 6%? Here Are 25 Stocks Moving In Thursday's Pre-Market Session ↗

July 21, 2022

Gainers Tuesday Morning Corporation (NASDAQ: TUEM) rose 72.1% to $0.3420 in pre-market trading after dipping 30% on Wednesday. Tuesday Morning recently announced partnership with Intalytics for...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 20, 2022

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 15.1% to $0.63 during Wednesday's after-market session. The company's market cap stands at $16.7 million.

Via Benzinga

Beyond Meat, Canoo, Veru And More: 12 Short Squeeze Candidates To Watch ↗

July 20, 2022

One of the most powerful tradable market events is a short squeeze, so traders are always on the lookout for the next short squeeze candidate. S3 Partners analyst Ihor Dusaniwsky has just released a...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 26, 2022

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

Via Benzinga

July 20, 2022

Gainers Applied Blockchain, Inc. (NASDAQ: APLD) shares climbed 100% to close at $2.12 on Tuesday after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and...

Via Benzinga

Why Did BMO Capital Markets Raise Price Target For Gene Stock One Month After Initiating Coverage ↗

July 18, 2022

Via Benzinga

Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday ↗

July 19, 2022

Gainers AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share.

Via Benzinga

Tesla, Coinbase Global And 41 Stocks Moving In Monday's Mid-Day Session ↗

July 18, 2022

Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) shares jumped 90.2% to $4.2792 after declining 11% on Friday. The company reported closing of $20.24 million initial public offering.

Via Benzinga

The Next CRISPR Is Here: How Verve Plans To Rival Amgen, Regeneron In Cholesterol ↗

July 12, 2022

This could offer an improvement over CRISPR, which requires cutting DNA.

Via Investor's Business Daily

Verve Therapeutics Amends Gene Editing Pact With Beam Therapeutics ↗

July 07, 2022

Verve Therapeutics Inc (NASDAQ: VERV) entered into an amended and restated collaboration and license Agreement with Beam Therapeutics Inc (NASDAQ:

Via Benzinga

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves ↗

May 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

June 14, 2022

On Tuesday, 951 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 25, 2022

On Monday, 721 companies achieved new lows for the year.

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

March 15, 2022

Gainers Incannex Healthcare Limited (NASDAQ: IXHL) shares jumped 131.6% to $53.10 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

April 21, 2022

On Thursday, 236 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 19, 2022

On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022 ↗

February 18, 2022

Upgrades Roth Capital upgraded the previous rating for Denbury Inc (NYSE:DEN) from Neutral to Buy. For the third quarter, Denbury had an EPS of $0.74, compared to year-ago...

Via Benzinga

68 Biggest Movers From Yesterday ↗

March 16, 2022

Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 19, 2022

Gainers Zogenix (NASDAQ:ZGNX) shares moved upwards by 67.2% to $26.15 during Wednesday's regular session. As of 12:30 EST, Zogenix's stock is trading at a volume...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 15, 2022

During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...

Via Benzinga

3 Synthetic Biology Stocks In Focus With Strong Potential ↗

December 26, 2021

Here we discuss three stocks engaged in the field of scientific biology that investors must follow, as they have the potential to generate wealth going forward.

Via Talk Markets

Meme Stock Breakdown ↗

December 14, 2021

There have been plenty of market happenings and themes in 2021 but perhaps one of the more intriguing ones was the recurring bouts of meme stock mania.

Via Talk Markets

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗

November 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...

Via Benzinga

Barron's Latest Picks And Pans: Alleghany, Blade Air Mobility, Gene Therapy Picks And More ↗

November 06, 2021

This weekend's Barron's cover story examines the bubbles in cryptocurrency, meme stocks and non-fungible tokens. Other featured articles discuss the stocks powering 2021...

Via Benzinga

Why Verve Therapeutics Is Up More Than 16% This Week ↗

October 28, 2021

The biotech stock rose nearly $7 a share from Monday through Thursday.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 30, 2021

Gainers OptimizeRx (NASDAQ:OPRX) stock increased by 12.12% to $84.05 during Thursday's pre-market session. The company's market cap stands at $1.4 billion....

Via Benzinga

Verve Therapeutics' Gene-Editing Therapy Shows Encouraging Preclinical Action In Cardiovascular Disease ↗

September 23, 2021

Verve Therapeutics Inc (NASDAQ: VERV) has reported new preclinical data from 36 non-human primates (NHPs) with its lead candidate, VERVE-101. VERVE-101 is a...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021 ↗

September 24, 2021

Upgrades Berenberg upgraded the previous rating for Tenable Holdings Inc (NASDAQ:

Via Benzinga

48 Biggest Movers From Friday ↗

September 20, 2021

Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by...

Via Benzinga

72 Biggest Movers From Yesterday ↗

September 14, 2021

Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Verve Therapeutics, Inc. - Common Stock (NQ:VERV)

Headline News about Verve Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today